Market Overview

Zogenix Shares Rally as FDA Redschedules Hydrocodone Drugs Panel

Share:
Related ZGNX
4 More Biotechs Leerink Is Looking At Post-Earnings
New Alzheimer's Trials Could Produce The Most Important Drugs In History

Shares of Zogenix (NASDAQ: ZGNX) rallied more than 10 percent on Tuesday following news the FDA rescheduled an advisory panel for hydrocodone drugs to January 24th-25th.

View pdf.

Posted-In: News FDA Movers

 

Related Articles (ZGNX)

View Comments and Join the Discussion!

Get Benzinga's Newsletters